Abstract | BACKGROUND: METHODS: RESULTS: The detection limit of the ELISA was 1.4ng/ml, and the intra- and inter- assay CVs were within 10%. Recovery of tumstatin added to sera was 92.7-115%. Patients with metastases had serum tumstatin levels 50% lower than patients without metastases (P=0.039). Tumstatin levels in poorly differentiated tumor tissues were significantly lower than in nontumorous tissues and well-differentiated tumor tissues (P<0.001). CONCLUSIONS: The development of a highly sensitive and reliable ELISA method capable of quantifying tumstatin in human serum samples and tissue extracts is reported. This assay for tumstatin in biological samples may be helpful in evaluating the therapeutic and/or prognostic value of tumstatin in cancer patients.
|
Authors | Yi-Qin Luo, Li-JuanYao, Liang Zhao, An-yuan Sun, Hang Dong, Jian-Ping Du, Shuang-Zheng Wu, Wen Hu |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 411
Issue 7-8
Pg. 510-5
(Apr 02 2010)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 20064495
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | 2010. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Autoantigens
- Collagen Type IV
- Recombinant Proteins
- type IV collagen alpha3 chain
|
Topics |
- Adult
- Aged
- Animals
- Autoantigens
(analysis, blood, isolation & purification)
- CHO Cells
- Collagen Type IV
(analysis, blood, isolation & purification)
- Cricetinae
- Cricetulus
- Enzyme-Linked Immunosorbent Assay
(methods)
- Female
- Humans
- Lung Neoplasms
(blood, diagnosis, metabolism)
- Male
- Mice
- Mice, Inbred BALB C
- Middle Aged
- Recombinant Proteins
(blood, isolation & purification)
|